Harvard Bioscience(HBIO) - 2024 Q1 - Quarterly Results

Exhibit 99.1 | Financial Results Summary | | | Three Months Ended March 31, | | | --- | --- | --- | --- | --- | | (unaudited, $ in millions except per share data) | | 2024 | | 2023 | | Revenues | $ | 24.5 | $ | 30.0 | | Gross margin | | 60.3% | | 61.2% | | Operating (loss) income (GAAP) | $ | (2.3) | $ | 1.7 | | Adjusted operating income | $ | 1.2 | $ | 4.4 | | Net (loss) income (GAAP) | $ | (4.7) | $ | 0.6 | | Diluted (loss) earnings per share (GAAP) | $ | (0.11) | $ | 0.01 | | Diluted adjusted earnings pe ...